| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1715 | Ddo-7132 | Novel NQO1 substrate, inhibiting cancer cell (NQO1-rich A549 cell line) growth |
|
| DCC1716 | Ddo-7204 | Novel Nrf2 activator |
|
| DCC1717 | ddpm-1457 | Potent mGAT4 inhibitor |
|
| DCC1718 | Ddr1-in-2 | Potent and selective DDR1 receptor tyrosine kinase inhibitor |
|
| DCC1719 | Ddri-18 | Inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin |
|
| DCC1720 | Ddr-trk-1n | Negative control for DDR-TRK-1 |
|
| DCC1721 | Dea Nonoate Sodium Salt | NO donor, generating a controlled release of nitric oxide in solution. |
|
| DCC1722 | Deacm-caged D-luciferin | Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm |
|
| DCC1723 | Deac-pda-atp | Fluorophore to myosin or actomyosin |
|
| DCC1724 | Debio-1452-nh3 | Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli |
|
| DCC1725 | Deferasirox Ferrate(iii) Tripotassium Complex | Deferasirox iron complex |
|
| DCC1726 | Deferoxamine Hydrochloride | Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile |
|
| DCC1727 | Degrader Bt1 | Novel selective degrader of BCR-ABL over c-ABL in leukemia cancer cells |
|
| DCC1728 | Dehydrorabelomycin | Natural polyketide matabolite |
|
| DCC1729 | Delcasertib | Novel selective δ-protein kinase C inhibitor |
|
| DCC1730 | Delta-tocopherol | Vitamin E variant, inhibiting prostate adenocarcinoma, lung tumorigenesis, promoting thermogenic gene expression via PGC-1α upregulation, preventing methylglyoxal-induced apoptosis by reducing ROS generation and inhibiting apoptotic signaling cascades |
|
| DCC1731 | Demethoxyviridin | Potent inhibitor of PI3 kinases |
|
| DCC1732 | Denagliptin Tosylate | Selective DPP-IV Inhibitor |
|
| DCC1733 | Denaverine Hydrochloride | Antispasmodic agent, improving the elasticity of the soft birth canal and regulating labor contractions |
|
| DCC1734 | Denosomin | Novel anti-Alzheimer's disease agent, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin |
|
| DCC1735 | Denv2-in-1 | Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described |
|
| DCC1736 | Denv2-in-2 | Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described |
|
| DCC1737 | Denv2-in-3 | Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described |
|
| DCC1738 | Deox B 7,4 | Novel reversible microtubule inhibitor, increasing lysosomal V-ATPase activity and lysosome acidity |
|
| DCC1739 | Deoxy-dalsir | Novel selective and sensitive near-infrared fluorescent probe for visualization of endogenous nitric oxide in living cells and animals |
|
| DCC1740 | Deoxynybomycin | Selective anti-tumor agent, inducing apoptosis and inhibiting topoisomerase I |
|
| DCC1741 | Depmpo | Most efficient spin trap for the in vitro and in vivo detection of O-, N-, S- and C-centered free radicals |
|
| DCC1742 | Dequalinium Bromide | HIV-1 fusion inhibitor, targeting the membrane-proximal external region of Env spikes, specifically inhibiting the HIV-1 envelope-mediated membrane fusion by blocking CD4-induced conformational changes |
|
| DCC1743 | Deramciclane Fumarate | Inhibitor of acetyl-CoA carboxylase (ACC), activating GPR40, inhibiting West Nile virus (WNV) infection and reducing the multiplication of Usutu virus (USUV), a WNV-related flavivirus |
|
| DCC1744 | Desfluoro Ezetimibe | Desfluoro impurity of Ezetimibe |
|
